News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Fortinet beat Q2 with $2.05B revenue (26% YoY) and raised 2026 revenue guidance to 19%, citing AI partnerships with Intel, Anthropic, OpenAI, NVIDIA.
  • Robinhood posted Q2 revenue up 32% to $1.31B, diluted EPS $0.62, record $22B net deposits and 4.8M Gold subscribers.
  • Tenable's Q2 revenue rose 8.6% to $268.5M with margin improvement, $100M buyback, and continued Anthropic/OpenAI collaborations.
  • Pfizer and BioNTech received EU authorization for their XFG-adapted COVID-19 vaccine, with manufacturing underway for the upcoming respiratory season.
  • Teladoc reported Q2 revenue down 4% to $606.9M, a $38.9M net loss, and expects slight full-year revenue decline amid BetterHelp headwinds.
  • Meritage Homes reported Q2 declines in homes closed, revenue, and margins, and trimmed 2026 expectations, signaling continued housing demand softness.

Latest Articles

WRAP® Advances Education Sector Expansion with Virtual Reality Training Purchase from William Paterson University

WRAP® Advances Education Sector Expansion with Virtual Reality Training Purchase from William Paterson University

Wrap Technologies announced that William Paterson University has purchased its WrapReality virtual reality training system to enhance the university's Criminology and Criminal Justice Program. This acquisition supports immersive learning for students and aligns with Wrap's strategy to expand its VR training platform beyond traditional law enforceme…

Trump Signals Large China Farm Purchases but Leaves Details Unclear

Trump Signals Large China Farm Purchases but Leaves Details Unclear

President Donald Trump told reporters aboard Air Force One that American farmers should be pleased with trade outcomes from his state visit to Beijing, saying China will be buying "billions of dollars" of soybeans. U.S. Trade Representative Jamieson Greer qualified the expectation as "double-digit billions" in U.S. agricultural purchases over the n…

Romania holds key rate at 6.5% as inflation stays in double digits

Romania holds key rate at 6.5% as inflation stays in double digits

The National Bank of Romania maintained its benchmark interest rate at 6.5%, the highest in the European Union, as the country confronts double-digit inflation and a worsening recession. The central bank adopted an updated inflation forecast that points to stronger-than-expected inflation in the second quarter - driven by fuel price rises and gover…

Private credit funds mark down loans as investor unease mounts

Private credit funds mark down loans as investor unease mounts

Major private credit managers and business development companies have recorded widespread markdowns across their loan portfolios in the first quarter, driven by market spread widening, borrower-specific issues and investor concerns about disruption. Aggregate fair-value measures declined, leaving roughly $1.2 billion of investments below amortized …

Franchisee-Backed Bid Sends Papa John’s Shares Higher Ahead of Market Open

Franchisee-Backed Bid Sends Papa John’s Shares Higher Ahead of Market Open

Papa John’s stock jumped sharply in pre-market trading after Nadeem Bajwa, the chain’s largest U.S. franchisee, joined Irth Capital in a proposal to take the company private. The bid, which offers $47 per share and represents a 44% premium to the most recent close, includes a commitment from Bajwa to make a "significant investment". The combination…

Jiuzi Holdings Subsidiary Jiuzi New York Inc. Signs Strategic MoU with AI Technology Company to Explore Next-Generation Intelligent Imaging and Data Solutions

Jiuzi Holdings Subsidiary Jiuzi New York Inc. Signs Strategic MoU with AI Technology Company to Explore Next-Generation Intelligent Imaging and Data Solutions

Jiuzi Holdings, Inc., through its subsidiary Jiuzi New York Inc., has signed a strategic Memorandum of Understanding with a top-tier AI technology company to collaboratively develop advanced AI-driven imaging platforms, cloud infrastructure, and scalable data management solutions. This partnership aims to enhance AI analytics capabilities across va…

Dominari Holdings' Early Stake in Cerebras Yields Roughly 9x Return After IPO

Dominari Holdings' Early Stake in Cerebras Yields Roughly 9x Return After IPO

Dominari Holdings said its early direct investment in AI-chip maker Cerebras Systems returned about nine times the initial capital after Cerebras’ May 14 IPO. Dominari Securities’ special purpose vehicles invested roughly $10 million at $39 per share, and with Cerebras shares closing at $311.07 on the first trading day, the firm estimates about $20…

Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting

Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting

Obagi Medical, part of Waldencast plc (NASDAQ: WALD), disclosed encouraging interim clinical and real-world data for its new skincare innovations: the NU-GEN Cellular Renewal Serum and Saypha® MagIQ™ injectable filler, presented at the Music City Symposium for Cosmetic Advances & Laser Education (SCALE). Data from over 300 clinical sites validate t…

Safe Pro Reports Record 560% Revenue Growth in First Quarter as Artificial Intelligence Sales Surge 2,400%, Delivering AI Gross Margins Over 72%

Safe Pro Reports Record 560% Revenue Growth in First Quarter as Artificial Intelligence Sales Surge 2,400%, Delivering AI Gross Margins Over 72%

Safe Pro Group Inc. (NASDAQ: SPAI) announced exceptional first quarter 2026 financial results with record revenue of $1.22 million, a 560% increase from the prior year, driven by a 2,400% surge in AI-powered product sales. The company’s AI solutions, including the NODE and NODE-X edge processing systems and the SPOTD threat detection platform, demo…

INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform

INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform

INmune Bio released Phase 2 MINDFuL trial results demonstrating positive trends for XPro™ (pegipanermin) in Alzheimer's patients with inflammatory biomarkers. The findings, published in NPJ Dementia, showed consistent benefit across multiple clinical and biomarker endpoints with no amyloid-related imaging abnormalities, validating the inflammation-…

CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients

CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients

CG Oncology reported positive interim results from its Phase 2 CORE-008 Cohort CX trial evaluating the combination of cretostimogene grenadenorepvec with gemcitabine in patients with high-risk non-muscle invasive bladder cancer (NMIBC) who are BCG-exposed or BCG-unresponsive. The study showed high complete response rates, strong high-grade event-fr…

UroGen Reports 94.5% Six-Month Duration of Response in Phase 3 UTOPIA Trial, Advancing UGN-103 Toward Potential Approval in Recurrent Low-Grade Intermediate-Risk NMIBC

UroGen Reports 94.5% Six-Month Duration of Response in Phase 3 UTOPIA Trial, Advancing UGN-103 Toward Potential Approval in Recurrent Low-Grade Intermediate-Risk NMIBC

UroGen Pharma reported that its investigational drug UGN-103 achieved a 94.5% six-month durability of response in the ongoing Phase 3 UTOPIA trial for patients with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC). The results align closely with the performance of ZUSDURI, the company's FDA-approved treatment i…

LifeMD to Participate in Upcoming Investor Conferences

LifeMD to Participate in Upcoming Investor Conferences

LifeMD, Inc., a leading virtual primary care platform, announced that its management will participate in the LD Micro Invitational XVI Conference and the B. Riley Securities 26th Annual Investor Conference in May 2026. The company aims to engage with investors through presentations and one-on-one meetings to discuss its telemedicine offerings and g…